 Michael Kosnett
Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Marijuana Smoking | 6 | 2024 | 247 | 2.240 |
Why?
| | Cannabis | 6 | 2024 | 465 | 1.750 |
Why?
| | Hallucinogens | 3 | 2024 | 102 | 1.630 |
Why?
| | Cannabinoids | 2 | 2023 | 153 | 1.420 |
Why?
| | Dronabinol | 5 | 2024 | 203 | 1.410 |
Why?
| | Occupational Exposure | 4 | 2023 | 299 | 1.280 |
Why?
| | Lead | 6 | 2023 | 56 | 1.060 |
Why?
| | Chelating Agents | 4 | 2014 | 68 | 0.970 |
Why?
| | Mercury Poisoning | 3 | 2013 | 6 | 0.890 |
Why?
| | Arsenic Poisoning | 3 | 2013 | 7 | 0.890 |
Why?
| | Air Pollutants, Occupational | 1 | 2023 | 32 | 0.800 |
Why?
| | Substance Abuse Detection | 4 | 2024 | 79 | 0.750 |
Why?
| | Occupational Health | 2 | 2023 | 192 | 0.740 |
Why?
| | Lead Poisoning | 6 | 2014 | 19 | 0.720 |
Why?
| | Chelation Therapy | 3 | 2013 | 11 | 0.600 |
Why?
| | Abdominal Pain | 2 | 2017 | 144 | 0.530 |
Why?
| | Anemia | 1 | 2017 | 160 | 0.510 |
Why?
| | Arsenicals | 2 | 2013 | 32 | 0.490 |
Why?
| | Workplace | 2 | 2023 | 247 | 0.470 |
Why?
| | Cesium | 1 | 2013 | 20 | 0.430 |
Why?
| | Cannabinoid Receptor Agonists | 2 | 2023 | 46 | 0.410 |
Why?
| | Chlorides | 1 | 2013 | 139 | 0.400 |
Why?
| | Sulfhydryl Reagents | 1 | 2012 | 12 | 0.390 |
Why?
| | Sulfides | 1 | 2012 | 94 | 0.370 |
Why?
| | Lead Poisoning, Nervous System, Adult | 1 | 2010 | 1 | 0.350 |
Why?
| | Nanostructures | 1 | 2011 | 100 | 0.340 |
Why?
| | Heart Arrest | 1 | 2013 | 321 | 0.320 |
Why?
| | Environmental Pollutants | 2 | 2013 | 143 | 0.320 |
Why?
| | Marijuana Abuse | 2 | 2024 | 234 | 0.310 |
Why?
| | Psychomotor Performance | 2 | 2022 | 313 | 0.310 |
Why?
| | Suicide, Attempted | 1 | 2012 | 349 | 0.310 |
Why?
| | United States Occupational Safety and Health Administration | 3 | 2023 | 7 | 0.300 |
Why?
| | Population Surveillance | 1 | 2011 | 439 | 0.290 |
Why?
| | Environmental Exposure | 3 | 2006 | 462 | 0.290 |
Why?
| | Succimer | 3 | 2014 | 4 | 0.250 |
Why?
| | Humans | 27 | 2024 | 129650 | 0.240 |
Why?
| | Eyelids | 1 | 2024 | 34 | 0.220 |
Why?
| | Distracted Driving | 1 | 2022 | 2 | 0.200 |
Why?
| | Administration, Inhalation | 1 | 2024 | 666 | 0.200 |
Why?
| | Motor Vehicles | 1 | 2022 | 31 | 0.190 |
Why?
| | Ventilation | 1 | 2022 | 40 | 0.190 |
Why?
| | Breast Neoplasms | 1 | 2013 | 2142 | 0.180 |
Why?
| | Accidents, Traffic | 1 | 2021 | 186 | 0.170 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2024 | 2012 | 0.170 |
Why?
| | Middle Aged | 8 | 2024 | 31154 | 0.170 |
Why?
| | Carbon Dioxide | 1 | 2022 | 260 | 0.170 |
Why?
| | Adult | 11 | 2024 | 35576 | 0.160 |
Why?
| | Schools | 1 | 2022 | 439 | 0.150 |
Why?
| | Models, Biological | 1 | 2024 | 1722 | 0.130 |
Why?
| | Oil and Gas Industry | 1 | 2016 | 7 | 0.130 |
Why?
| | Hydrocarbons | 1 | 2016 | 27 | 0.130 |
Why?
| | Inhalation Exposure | 1 | 2016 | 91 | 0.120 |
Why?
| | Death, Sudden, Cardiac | 1 | 2016 | 179 | 0.110 |
Why?
| | Water Supply | 3 | 2002 | 75 | 0.110 |
Why?
| | Biomarkers | 2 | 2023 | 3973 | 0.110 |
Why?
| | Unithiol | 1 | 2013 | 2 | 0.110 |
Why?
| | Arsenic | 3 | 2002 | 66 | 0.110 |
Why?
| | Pandemics | 1 | 2022 | 1488 | 0.110 |
Why?
| | Injections, Intralesional | 1 | 2013 | 34 | 0.110 |
Why?
| | Administration, Oral | 2 | 2014 | 786 | 0.110 |
Why?
| | United States | 5 | 2023 | 13903 | 0.100 |
Why?
| | Fatal Outcome | 1 | 2013 | 300 | 0.100 |
Why?
| | Long QT Syndrome | 1 | 2013 | 67 | 0.100 |
Why?
| | Therapeutic Irrigation | 1 | 2012 | 75 | 0.090 |
Why?
| | Nausea | 1 | 2012 | 110 | 0.090 |
Why?
| | Fluid Therapy | 1 | 2012 | 134 | 0.090 |
Why?
| | Bone and Bones | 1 | 1994 | 299 | 0.090 |
Why?
| | Heavy Metal Poisoning | 1 | 2010 | 3 | 0.090 |
Why?
| | Occupational Diseases | 2 | 2005 | 138 | 0.080 |
Why?
| | Government Regulation | 1 | 2010 | 49 | 0.080 |
Why?
| | Electrocardiography | 1 | 2013 | 608 | 0.080 |
Why?
| | Young Adult | 2 | 2024 | 12426 | 0.080 |
Why?
| | Intestines | 1 | 2012 | 348 | 0.080 |
Why?
| | California | 1 | 2010 | 401 | 0.080 |
Why?
| | Female | 8 | 2024 | 68776 | 0.070 |
Why?
| | Acute Disease | 1 | 2010 | 980 | 0.070 |
Why?
| | Male | 8 | 2024 | 63681 | 0.070 |
Why?
| | Animals | 6 | 2013 | 35361 | 0.070 |
Why?
| | Laboratories | 1 | 2006 | 110 | 0.060 |
Why?
| | Lactation | 1 | 2006 | 170 | 0.060 |
Why?
| | Guidelines as Topic | 1 | 2006 | 264 | 0.060 |
Why?
| | Plastics | 1 | 2005 | 47 | 0.060 |
Why?
| | Chronic Disease | 1 | 2010 | 1720 | 0.060 |
Why?
| | Reproducibility of Results | 2 | 2024 | 3083 | 0.060 |
Why?
| | Tremor | 1 | 2024 | 60 | 0.050 |
Why?
| | Age Factors | 1 | 2010 | 3144 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2020 | 1952 | 0.050 |
Why?
| | Risk Assessment | 1 | 2010 | 3240 | 0.040 |
Why?
| | Indians, South American | 1 | 2000 | 23 | 0.040 |
Why?
| | Biotransformation | 1 | 2020 | 66 | 0.040 |
Why?
| | Time Factors | 1 | 2010 | 6556 | 0.040 |
Why?
| | Urinalysis | 1 | 2020 | 75 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2013 | 10230 | 0.040 |
Why?
| | Skin Diseases | 1 | 2000 | 143 | 0.040 |
Why?
| | Computer Simulation | 1 | 2022 | 943 | 0.040 |
Why?
| | Nutritional Status | 1 | 2000 | 328 | 0.040 |
Why?
| | Genetic Variation | 1 | 2002 | 937 | 0.030 |
Why?
| | Gas Poisoning | 1 | 2016 | 4 | 0.030 |
Why?
| | Nigeria | 1 | 2014 | 16 | 0.030 |
Why?
| | Body Burden | 1 | 1994 | 7 | 0.030 |
Why?
| | Pregnancy | 1 | 2006 | 6402 | 0.030 |
Why?
| | Suburban Population | 1 | 1994 | 16 | 0.030 |
Why?
| | Pennsylvania | 1 | 1994 | 108 | 0.030 |
Why?
| | Weapons | 1 | 2013 | 8 | 0.030 |
Why?
| | Fluorescence | 1 | 1994 | 160 | 0.030 |
Why?
| | Demography | 1 | 1994 | 279 | 0.030 |
Why?
| | Age Distribution | 1 | 1994 | 372 | 0.030 |
Why?
| | Sex Distribution | 1 | 1994 | 359 | 0.030 |
Why?
| | Water Pollutants | 1 | 1992 | 20 | 0.020 |
Why?
| | Tibia | 1 | 1994 | 170 | 0.020 |
Why?
| | Dimercaprol | 1 | 1992 | 6 | 0.020 |
Why?
| | Edetic Acid | 1 | 1992 | 46 | 0.020 |
Why?
| | Radiography | 1 | 1994 | 798 | 0.020 |
Why?
| | Regression Analysis | 1 | 1994 | 993 | 0.020 |
Why?
| | Poisoning | 1 | 1992 | 111 | 0.020 |
Why?
| | Risk | 1 | 2013 | 854 | 0.020 |
Why?
| | Hypoxia | 1 | 2016 | 1084 | 0.020 |
Why?
| | Maximum Allowable Concentration | 2 | 1998 | 14 | 0.020 |
Why?
| | Adolescent | 3 | 2002 | 20393 | 0.010 |
Why?
| | Renal Insufficiency | 1 | 2005 | 149 | 0.010 |
Why?
| | Child | 3 | 2002 | 20883 | 0.010 |
Why?
| | Nuclear Family | 1 | 2002 | 51 | 0.010 |
Why?
| | Methylation | 1 | 2002 | 230 | 0.010 |
Why?
| | Family Health | 1 | 2002 | 198 | 0.010 |
Why?
| | Infant | 1 | 2014 | 9024 | 0.010 |
Why?
| | Chile | 1 | 2000 | 20 | 0.010 |
Why?
| | Child, Preschool | 1 | 2014 | 10517 | 0.010 |
Why?
| | Occupational Health Nursing | 1 | 1998 | 1 | 0.010 |
Why?
| | Neoplasms | 1 | 1992 | 2470 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 14518 | 0.010 |
Why?
| | Aged | 1 | 1994 | 22103 | 0.010 |
Why?
| | Incidence | 1 | 2000 | 2644 | 0.010 |
Why?
| | Taiwan | 1 | 1992 | 19 | 0.010 |
Why?
| | United States Environmental Protection Agency | 1 | 1992 | 23 | 0.010 |
Why?
| | Diet | 1 | 2000 | 1213 | 0.010 |
Why?
| | Rats, Wistar | 1 | 1992 | 441 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 1998 | 1501 | 0.010 |
Why?
| | Urinary Bladder Neoplasms | 1 | 1992 | 228 | 0.000 |
Why?
| | Kidney Neoplasms | 1 | 1992 | 350 | 0.000 |
Why?
| | Liver Neoplasms | 1 | 1992 | 640 | 0.000 |
Why?
| | Case-Control Studies | 1 | 1992 | 3381 | 0.000 |
Why?
| | Risk Factors | 1 | 1998 | 9765 | 0.000 |
Why?
| | Rats | 1 | 1992 | 5500 | 0.000 |
Why?
| | Lung Neoplasms | 1 | 1992 | 2344 | 0.000 |
Why?
| | Mice | 1 | 1992 | 16937 | 0.000 |
Why?
|
|
Kosnett's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|